We are seeking a highly motivated individual to undertake a PhD in health economics in prostate cancer. The Centre for Health Economics Research and Evaluation (CHERE) has been invited by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) to collaborate on the international project: Intermediate Clinical Endpoints for Cancer of the Prostate (ICECaP). ICECaP is using data from more than 28,900 prostate cancer patients to test and validate an intermediate clinical outcome for use as a surrogate for overall survival in men with prostate cancer.
Download a submission pack here
